Chi Sheng Pharma & Biotech Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 263.17 million compared to TWD 275.87 million a year ago. Net income was TWD 18.72 million compared to TWD 26.12 million a year ago.

Basic earnings per share from continuing operations was TWD 0.33 compared to TWD 0.59 a year ago. Diluted earnings per share from continuing operations was TWD 0.33 compared to TWD 0.59 a year ago. Basic earnings per share was TWD 0.33 compared to TWD 0.46 a year ago.

Diluted earnings per share was TWD 0.33 compared to TWD 0.46 a year ago.